相关实验视频
Updated: May 12, 2026

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
23.5K
代谢和腹部手术后坚和减肥之间的关联
Zachary N Weitzner1, Hila Zelicha1, Erik P Dutson1
1Section of Bariatric Surgery, Department of Surgery, David Geffen UCLA School of Medicine, Los Angeles, CA, 90095, USA.
Obesity surgery
|September 23, 2024
概括
一个人格特质的勇气,在代谢和减肥手术 (MBS) 后的一年没有与减肥相关. 这表明MBS诱导的体重减轻可能独立于患者长期目标实现能力.
科学领域:
- 腹部外科 腹部外科
- 心理学 心理学 心理学
- 肥胖问题研究研究
背景情况:
- 坚被定义为对长期目标的力和热情.
- 肥胖是一种复杂的疾病,通常需要大幅改变生活方式.
- 代谢和减肥手术 (MBS) 是对肥胖的有效治疗方法.
研究的目的:
- 为了研究个性特征坚和MBS后体重减轻之间的关系.
- 为了确定灰是否影响腹腔镜袖胃切除术 (LSG) 后减肥的成功.
主要方法:
- 一项前性队列研究包括104名接受LSG的成年患者.
- 进行了手术前的坚调查问卷,以评估人格特征.
- 使用ANCOVA评估了手术后一年的体重减轻,与坚分数相关.
主要成果:
- 74名患者 (72.1%) 在一年后完成了随访,实现了28.4%的总体体重减轻 (TBW).
- 从手术前到手术后的一年,Grit评分保持稳定.
- 在手术前的坚度得分 (总或域) 和一年的体重减轻之间没有发现显著的关联.
结论:
- 在MBS后一年,Grit与体重减轻没有相关性.
- 无论一个人的坚程度如何,MBS可能会促进减肥.
- 在这种情况下,手术似乎是减肥的主要驱动因素.
相关概念视频
Metabolic States of the Body: The Postabsorptive State
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

